Chapter 19

S00–T88: Injury, Poisoning and Certain Other Consequences of External Causes

Injury, Poisoning and Certain Other Consequences of External Causes diagnostic classification updated for 2026.

Chapter Instructions

Excludes2(Not included here. Code separately if applicable.)
Use Additional Code
  • code to identify any retained foreign body, if applicable (Z18.-)
Internal Codes
  • T44.3X3A|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter

  • T44.3X3D|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter

  • T44.3X3S|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela

  • T44.3X4|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined

  • T44.3X4A|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter

  • T44.3X4D|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter

  • T44.3X4S|

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela

  • T44.3X5|

    Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

  • T44.3X5A|

    Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

  • T44.3X5D|

    Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

  • T44.3X5S|

    Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

  • T44.3X6|

    Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics

  • T44.3X6A|

    Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

  • T44.3X6D|

    Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

  • T44.3X6S|

    Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

  • T44.4|

    Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists

  • T44.4X|

    Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists

  • T44.4X1|

    Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)

  • T44.4X1A|

    Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter

  • T44.4X1D|

    Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

  • T44.4X1S|

    Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela

  • T44.4X2|

    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm

  • T44.4X2A|

    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter

  • T44.4X2D|

    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter

  • T44.4X2S|

    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela

  • T44.4X3|

    Poisoning by predominantly alpha-adrenoreceptor agonists, assault

  • T44.4X3A|

    Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter

  • T44.4X3D|

    Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter

  • T44.4X3S|

    Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela

  • T44.4X4|

    Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined

  • T44.4X4A|

    Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter

  • T44.4X4D|

    Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter

  • T44.4X4S|

    Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela

  • T44.4X5|

    Adverse effect of predominantly alpha-adrenoreceptor agonists

  • T44.4X5A|

    Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter

  • T44.4X5D|

    Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter

  • T44.4X5S|

    Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela

  • T44.4X6|

    Underdosing of predominantly alpha-adrenoreceptor agonists

  • T44.4X6A|

    Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter

  • T44.4X6D|

    Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter

  • T44.4X6S|

    Underdosing of predominantly alpha-adrenoreceptor agonists, sequela

  • T44.5|

    Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

  • T44.5X|

    Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

  • T44.5X1|

    Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)

  • T44.5X1A|

    Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter

  • T44.5X1D|

    Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

  • T44.5X1S|

    Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela

  • T44.5X2|

    Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm

  • T44.5X2A|

    Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter

  • T44.5X2D|

    Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter

PreviousPage 933 of 1086Next